Skip to main content
    I

    Instil Bio Inc. (TIL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.95
    -0.23 (-3.72%)

    Market Cap: $40.35M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    32%(7/22)
    Avg Surprise
    -4.53%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.17
    Range$-0.17 - $-0.17
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.33+48.5%
    60d ago$-0.33+48.5%
    30d ago$-0.170.0%
    7d ago$-0.170.0%
    Current$-0.17
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.06---
    Sep 26EST
    		-$-0.17---
    Jun 26
    Reported Aug 13
    		$-0.63$-0.35-80.00%Miss+78.1%
    Mar 26
    Reported May 15
    		$-0.62$-0.59-5.08%Miss+85.6%
    Dec 25
    Reported Mar 27
    		$-0.97N/A+74.34%Beat+10.2%
    Sep 25
    Reported Nov 13
    		$-2.01$-2.35+14.47%Beat+21.2%
    Jun 25
    Reported Aug 13
    		$-2.88$-2.44-18.03%Miss-83.4%
    Mar 25
    Reported May 13
    		$-4.32$-2.59-66.80%Miss-15.5%
    Dec 24
    Reported Mar 4
    		$-1.08N/A+70.41%Beat+14.3%
    Sep 24
    Reported Nov 13
    		$-2.55$-3.08+17.21%Beat+20.3%
    Jun 24
    Reported Aug 13
    		$-1.57$-3.04+48.36%Beat+28.6%
    Mar 24
    Reported May 10
    		$-3.74$-2.23-67.71%Miss+25.2%
    Dec 23
    Reported Mar 21
    		$-1.26N/A+62.94%Beat-425.0%
    Sep 23
    Reported Nov 13
    		$-3.20$-3.00-6.67%Miss+62.8%
    Jun 23
    Reported Aug 14
    		$-2.20$-2.00-10.00%Miss+76.1%
    Mar 23
    Reported May 11
    		$-5.00$-3.20-56.25%Miss+40.5%
    Dec 22
    Reported Mar 27
    		$-0.24$-0.41+41.46%Beat+44.2%
    Sep 22
    Reported Nov 14
    		$-8.60$-8.20-4.88%Miss-30.3%
    Jun 22
    Reported Aug 12
    		$-9.20$-8.27-11.25%Miss-70.4%
    Mar 22
    Reported May 16
    		$-8.40$-6.50-29.23%Miss+36.4%
    Dec 21
    Reported Mar 7
    		$-0.43$-0.36-19.44%Miss-186.7%
    Sep 21
    Reported Nov 15
    		$-6.60$-6.13-7.67%Miss-
    Jun 21
    Reported Aug 12
    		$-5.40$-4.00-35.00%Miss-
    Mar 21
    Reported May 13
    		$-13.20$-11.90-10.92%Miss-
    Dec 20
    Reported Mar 22
    		$-0.15$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.41EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-25.30%ROIC-15.39%
    Financial Health
    Debt/Equity0.79xInterest Coverage-5.97x
    Current Ratio21.67xQuick Ratio21.67x
    Trading Statistics
    Beta1.94Avg Volume21.14K
    52-Week High$20.3352-Week Low$5.67

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.72
    SMA 20$6.93
    SMA 50$7.27
    SMA 200$7.85
    EMA 10$6.60
    EMA 20$6.85
    EMA 50$7.17
    EMA 200$9.08

    MACD

    Line: -0.28Signal: -0.18Hist: -0.10

    ADX

    ADX: 22.0+DI: 9.2-DI: 32.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$7.04

    Bollinger Bands

    Upper Band$7.66
    Lower Band$6.21
    %B Position2094%(Upper)
    Band Width-0.18

    RSI (14-Day)

    Oversold
    23.1

    Momentum Oscillators

    Stoch %K9.6
    Stoch %D16.8
    Williams %R-98.7
    ROC (10d)-17.8%
    Momentum-1.29
    CCI (20d)-232.2
    MFI (14d)28.7

    Volatility Measures

    ATR (14d)$0.28(4.7%)
    StdDev (20d)0.36
    Hist Vol36.9%(Moderate)

    Volume Flow

    VWAP$6.03
    OBV-405.5K
    AD Line-3.6M
    CMF (20d)-0.242

    Volume Metrics

    Avg Vol (20d)22.0K
    Vol Ratio2.0x(High)
    VWMA (20d)$6.81

    Pivot Points

    R3$7.10
    R2$6.86
    R1$6.52
    Pivot Point$6.27
    S1$5.93
    S2$5.69
    S3$5.35

    Advanced Oscillators

    TSI-34.45
    Ultimate Osc31.7
    KST-86.92

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$3.99M$0$0$0$7.67M$0
    Cost of Revenue$0$0$12,000$0$0$0$741,000$0$0$0$1.04M$0
    Gross Profit$0$0$-12,000$0$0$0$-741,000$0$0$0$-1,036,000$0
    Operating Expenses$5.58M$5.39M$9.56M$15.02M$23.44M$30.56M$11.82M$23.63M$14.13M$23.95M$13.02M$66.72M
    R&D$270,000$669,000$3.50M$9.13M$16.74M$5.37M$1.10M$10.56M$2.92M$7.26M$1.98M$8.49M
    SG&A$5.13M$5.35M$6.06M$5.89M$6.16M$9.11M$10.37M$10.71M$10.71M$12.42M$10.87M$11.94M
    Operating Income$-5,581,000$-7,010,000$-9,557,000$-15,022,000$-23,440,000$-30,562,000$-11,820,000$-23,631,000$-14,135,000$-23,955,000$-13,020,000$-66,716,000
    Interest Income$2.87M$2.92M$2.99M$3.13M$3.29M$3.42M$4.13M$3.15M$1.92M$2.06M$2.19M$2.31M
    Interest Expense$1.58M$1.55M$1.57M$1.58M$1.58M$1.10M$3.00M$2.01M$2.00M$1.98M$1.98M$2.00M
    Income Before Tax$-4,289,000$-4,204,000$-8,191,000$-13,587,000$-21,394,000$-28,243,000$-11,895,000$-23,021,000$-14,917,000$-24,302,000$-12,925,000$-67,432,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-4,299,000$-4,204,000$-8,191,000$-13,587,000$-21,394,000$-28,200,000$-11,895,000$-23,021,000$-14,917,000$-24,302,000$-12,925,000$-67,432,000
    EBITDA$-5,253,000$-7,002,000$-9,600,000$-15,128,000$-23,031,000$-30,300,000$-12,275,000$-23,260,000$-13,862,000$-23,390,000$-12,104,000$-66,789,000
    EBIT$-5,581,000$-7,192,000$-9,612,000$-15,140,000$-23,098,000$-30,562,000$-13,016,000$-24,161,000$-14,837,000$-24,383,000$-13,140,000$-67,742,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TIL

    News

    How (TIL) Movements Inform Risk Allocation Models

    This article analyzes Instil Bio Inc. (NYSE: TIL) using AI models, indicating weak sentiment across all time horizons and supporting a short bias. It outlines three trading strategies—Position, Momentum Breakout...

    Stock Traders Daily•10/15/26•Bearish

    Trading the Move, Not the Narrative: (TIL) Edition

    This article analyzes Instil Bio Inc. (NYSE: TIL), highlighting a positive near-term sentiment that may shift and a mid-channel oscillation pattern. It identifies an exceptional short setup with a 124.0:1 risk-reward...

    Stock Traders Daily•10/5/26•Bearish

    Trading the Move, Not the Narrative: (TIL) Edition

    This article analyzes Instil Bio Inc. (NYSE: TIL) using AI models to suggest trading strategies based on different risk profiles. It identifies a potential short setup with a favorable risk-reward ratio...

    Stock Traders Daily•10/5/26•Bearish

    Press Release: Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

    This press release from Instil Bio reports the company's financial results for the second quarter of 2026 and provides a corporate update. It will detail key financial figures and potentially strategic developments...

    Moomoo•9/5/26•Neutral

    (TIL) Movement as an Input in Quant Signal Sets

    This article analyzes Instil Bio Inc. (NYSE: TIL) using AI models, revealing mixed sentiment and potential choppiness. It presents three trading strategies—Position, Momentum Breakout...

    Stock Traders Daily•9/4/26•Somewhat-Bearish

    TIL Valuation and Fair Value

    P/E
    -1.4x
    P/B
    0.4x
    See GNG's fair value

    TIL Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -15.4%
    ROE
    -25.3%

    TIL Competitors

    CompanyTicker
    Precipio IncPRPO
    Nano X Imaging LtdNNOX
    Ekso Bionics Holdings IncEKSO
    Grace Therapeutics, Inc.GRCE
    PureTech Health PLCPRTC
    Scynexis IncSCYX
    Tevogen Bio Holdings Inc.TVGN
    CVRx IncCVRX

    Sector: Healthcare

    TIL Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    0.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.17
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About TIL

    Does TIL pay dividends?

    Instil Bio Inc. (TIL) does not currently pay a regular dividend.

    What is TIL's market cap?

    Instil Bio Inc. (TIL) has a market capitalization of $40.35M with a current stock price of $5.95.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In